Sustainable Finance > Food

Our clients' investments reach out today to 355,443 enterprises and households in rural areas and to 171,125 enterprises and households active in agriculture. more

 

Sustainable Finance > Homes

Our clients' investments reach out today to 42,246 small housing, property and infrastructure projects. more

 

Sustainable Finance > Jobs

Our clients' investments reach out today to 728,459 micro, small and medium enterprises and support the employment of over 4 million people in 48 emerging economies. more

 

Sustainable Finance > Energy

Many of Symbiotics' partner financial institutions are engaged in developing sustainable energy financing products. more

 

Research & Advisory

Our Research & Analysis team has placed USD 1.9 billion in micro- & SME finance investments, through nearly 1,900 deals split between 28 funds/investors and 200 financial institutions in over 50 emerging economies.

Learn more

Asset Management

Our Asset Management team manages seven microfinance and SME impact funds, and one sustainable fund of fund, with USD 400 million of assets under management held by development banks, institutional and qualified private investors.

Learn more

Investor Relations

Our Investor Relations team has set up over a dozen impact investing funds/strategies and raised over USD 350 million of assets. The team currently markets several new products to specialized and qualified investors.

Learn more

Legal Disclaimer: The collective investment schemes (the “Investment Products”) referred to on the following pages have not been approved for public distribution in or from Switzerland by the Swiss Financial Market Supervisory Authority (FINMA) pursuant to the Swiss Collective Investment Schemes Act of 23 June 2006 (the "CISA") and its implementing regulations. Accordingly, units of such Investment Products and information, documents or material pertaining to these Investment Products on the following pages may only be distributed in or from Switzerland to qualified investors (as such term is defined in the CISA and its implementing regulations). The information, documents and material pertaining to these Investment Products on the following pages are strictly confidential and do not constitute an offer to any other person or entity than Swiss qualified investors and may only be used by those qualified investors who have accessed them. They may not be copied, used by, distributed or made available to any other person.

Similarly the information on the following pages is only intended to be viewed by persons who fall outside the scope of any law that seeks to regulate financial promotions in the country of your residence or in the country in which the content of this website is being viewed.

If you are uncertain about your position under the laws of the country in which the content of this website is being viewed then you should seek clarification by obtaining legal advice from a lawyer practicing in the country of your residence or in the country in which the content of this website is being viewed before accessing this website.

The information, documents and material contained in the following pages are not warranted to be accurate, complete, or timely. More specifically, Symbiotics SA may not be held responsible for and does not take any position with respect to the accuracy and completeness of information in the following pages.

Agree    Disagree